CellsExpress: Affordable, Bulk Isolated Bone Marrow-Derived Stem Cells That Accelerate Your Cell and Gene Therapy Research 

CellsExpress: Affordable, Bulk Isolated Bone Marrow-Derived Stem Cells That Accelerate Your Cell and Gene Therapy Research 

By Joanna Wirkus  Bulk Bone Marrow Stem Cells for Research | CGT Global The race to develop life-saving cell and gene therapies is intensifying. Amid shifting political pressures, uncertain funding landscapes, and rising inflation, scientists are being asked to do more with less. Time, money, and labor must be optimized at every step—and that starts…

For More Information

Optimizing Gene and Cell Therapy Research by Starting with Properly Sourced Human Bone Marrow Cells

Using Quality Human Bone Marrow Cells to Optimize Cell and Gene Therapy Research

By: Joanna Wirkus Bone Marrow Cells: Critical Tools Driving Stem Cell and Gene Therapy Innovation Surprisingly safe and well tolerated, the first bone marrow biopsy was performed on the shinbone in 1908 by Italian physician Giovanni Ghedini. Today, bone marrow continues to be an important source of information about the health status of individuals with…

For More Information

Gene Therapy Research: Past, Present, Future

CGT Global Blog - Gene Therapy Research Past, Present, Future

  Gene Therapy Research: Past, Present, Future By: Joanna Wirkus Gene Therapy: Where We’ve Been: The Human Genome Project concluded in 2003 after 13 years of effort aimed at mapping the entire Human Genome and improving DNA sequencing technology at large. This milestone set the foundation for a better understanding of the drivers of disease…

For More Information

Overcoming Challenges with Animal Models in Research

Overcoming Challenges with Animal Models in Research –  How Starting With the Right Cells Can Improve Science That Saves Lives  BY JOANNA WIRKUS  One estimate reports that more than 100 million mice are used in biomedical research each year in the U.S. Mus musculus, the most common model organism, has been the foundation of biological…

For More Information

EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures

CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract Research Organization (CRO) and biotech manufacturer, announced today it has received approval from Western Copernus Group (WCG) to provide disease…

For More Information

EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures

CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell collection and manufacturing, CGT Global announced today it is partnering with Austin Financial Services, Inc., a leading national middle…

For More Information

EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States

FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global…

For More Information

Webinar: Access to Cell and Gene Therapies

Thumbnail image - Webinar playback

Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions during the session were truly remarkable, and we want to extend our heartfelt gratitude to all who participated. Missed…

For More Information

CGT Global Launches CellsExpress Bulk Cell Isolation

StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…

For More Information

AARC Annual Meeting 2022

March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is…

For More Information